PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Maximized (PSO Pain)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


JANX 17.58%ASTS 13.45%WGS 10.55%DOGZ 9.95%CADL 8.92%MDIA 8.64%SEZL 7.33%FTEL 5.9%CRBP 5.3%INSG 4.63%LASE 2.36%TIL 2.2%RZLT 2.12%SMMT 1.07%EquityEquity
PositionCategory/SectorTarget Weight
ASTS
AST SpaceMobile, Inc.
Communication Services
13.45%
CADL
Candel Therapeutics, Inc.
Healthcare
8.92%
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
5.30%
DOGZ
Dogness (International) Corporation
Consumer Defensive
9.95%
FTEL
Fitell Corporation Ordinary Shares
Consumer Cyclical
5.90%
INSG
Inseego Corp.
Technology
4.63%
JANX
Janux Therapeutics, Inc.
Healthcare
17.58%
LASE
Laser Photonics Corporation
Industrials
2.36%
MDIA
MediaCo Holding Inc.
Communication Services
8.64%
RZLT
Rezolute, Inc.
Healthcare
2.12%
SEZL
Sezzle Inc. Common Stock
Financial Services
7.33%
SMMT
Summit Therapeutics Inc.
Healthcare
1.07%
TIL
Instil Bio, Inc.
Healthcare
2.20%
WGS
GeneDx Holdings Corp.
Healthcare
10.55%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Maximized (PSO Pain), comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


0.00%100.00%200.00%300.00%400.00%500.00%NovemberDecember2025FebruaryMarchApril
350.24%
20.88%
Maximized (PSO Pain)
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Aug 17, 2023, corresponding to the inception date of SEZL

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
-10.18%-6.92%-9.92%5.42%12.98%9.70%
Maximized (PSO Pain)-13.31%-11.05%-14.08%75.90%N/AN/A
ASTS
AST SpaceMobile, Inc.
10.85%-8.81%-16.88%992.99%18.96%N/A
CADL
Candel Therapeutics, Inc.
-47.35%-48.65%-24.59%-16.30%N/AN/A
CRBP
Corbus Pharmaceuticals Holdings, Inc.
-48.90%0.00%-67.25%-83.49%-49.30%-23.12%
DOGZ
Dogness (International) Corporation
-64.34%-44.55%-59.45%141.73%-5.93%N/A
FTEL
Fitell Corporation Ordinary Shares
-92.68%-12.21%-96.50%-91.78%N/AN/A
INSG
Inseego Corp.
-28.95%-23.34%-62.25%201.24%-42.76%-18.92%
JANX
Janux Therapeutics, Inc.
-44.55%-3.95%-40.66%-39.22%N/AN/A
LASE
Laser Photonics Corporation
-52.94%-23.38%-56.34%20.89%N/AN/A
MDIA
MediaCo Holding Inc.
2.19%-1.27%-37.37%-57.17%-20.02%N/A
RZLT
Rezolute, Inc.
-43.88%-17.42%-43.30%-16.67%-8.94%-31.51%
SEZL
Sezzle Inc. Common Stock
5.08%16.81%19.24%357.53%N/AN/A
SMMT
Summit Therapeutics Inc.
37.91%22.38%16.03%601.14%43.16%7.84%
TIL
Instil Bio, Inc.
-19.04%-22.22%-58.73%48.46%N/AN/A
WGS
GeneDx Holdings Corp.
24.21%-2.02%58.98%897.60%N/AN/A
*Annualized

Monthly Returns

The table below presents the monthly returns of Maximized (PSO Pain), with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.02%11.94%-17.94%2.61%-13.31%
202411.46%96.25%-0.68%55.73%22.13%17.09%7.45%12.44%-1.50%20.04%-2.69%-6.50%528.74%
20230.05%-16.98%-24.81%11.48%18.63%-17.40%

Expense Ratio

Maximized (PSO Pain) has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 97, Maximized (PSO Pain) is among the top 3% of portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of Maximized (PSO Pain) is 9797
Overall Rank
The Sharpe Ratio Rank of Maximized (PSO Pain) is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of Maximized (PSO Pain) is 9797
Sortino Ratio Rank
The Omega Ratio Rank of Maximized (PSO Pain) is 9595
Omega Ratio Rank
The Calmar Ratio Rank of Maximized (PSO Pain) is 9898
Calmar Ratio Rank
The Martin Ratio Rank of Maximized (PSO Pain) is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for Portfolio, currently valued at 1.23, compared to the broader market-4.00-2.000.002.00
Portfolio: 1.23
^GSPC: 0.24
The chart of Sortino ratio for Portfolio, currently valued at 1.93, compared to the broader market-6.00-4.00-2.000.002.004.00
Portfolio: 1.93
^GSPC: 0.47
The chart of Omega ratio for Portfolio, currently valued at 1.22, compared to the broader market0.400.600.801.001.201.401.60
Portfolio: 1.22
^GSPC: 1.07
The chart of Calmar ratio for Portfolio, currently valued at 2.17, compared to the broader market0.001.002.003.004.005.006.00
Portfolio: 2.17
^GSPC: 0.24
The chart of Martin ratio for Portfolio, currently valued at 6.30, compared to the broader market0.005.0010.0015.0020.00
Portfolio: 6.30
^GSPC: 1.08

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ASTS
AST SpaceMobile, Inc.
6.945.631.6215.6136.72
CADL
Candel Therapeutics, Inc.
-0.160.791.10-0.31-0.44
CRBP
Corbus Pharmaceuticals Holdings, Inc.
-0.88-1.590.77-0.93-1.40
DOGZ
Dogness (International) Corporation
0.902.191.301.984.79
FTEL
Fitell Corporation Ordinary Shares
-0.430.351.05-0.92-1.49
INSG
Inseego Corp.
2.162.681.373.427.03
JANX
Janux Therapeutics, Inc.
-0.50-0.490.95-0.64-1.20
LASE
Laser Photonics Corporation
0.101.711.230.220.33
MDIA
MediaCo Holding Inc.
-0.390.111.01-0.65-0.84
RZLT
Rezolute, Inc.
-0.240.201.02-0.33-0.76
SEZL
Sezzle Inc. Common Stock
2.343.501.435.5112.07
SMMT
Summit Therapeutics Inc.
2.015.671.7210.8219.15
TIL
Instil Bio, Inc.
0.322.031.220.590.93
WGS
GeneDx Holdings Corp.
7.436.081.6923.1272.62

The current Maximized (PSO Pain) Sharpe ratio is 2.53. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.22 to 0.77, this portfolio's current Sharpe ratio is in the top 25%, it signifies superior risk-adjusted performance. This means that for the level of risk undertaken, the portfolio is generating impressive returns compared to most others.

Use the chart below to compare the Sharpe ratio of Maximized (PSO Pain) with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.002.004.006.008.0010.0012.00NovemberDecember2025FebruaryMarchApril
1.23
0.24
Maximized (PSO Pain)
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield


Maximized (PSO Pain) doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-24.76%
-14.02%
Maximized (PSO Pain)
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the Maximized (PSO Pain). A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Maximized (PSO Pain) was 42.47%, occurring on Nov 9, 2023. Recovery took 69 trading sessions.

The current Maximized (PSO Pain) drawdown is 38.27%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.47%Aug 31, 202350Nov 9, 202369Feb 21, 2024119
-33.55%Oct 30, 2024107Apr 4, 2025
-14.95%Apr 12, 20247Apr 22, 20247May 1, 202414
-13.06%Sep 16, 202414Oct 3, 20249Oct 16, 202423
-12.58%Jul 17, 202416Aug 7, 20245Aug 14, 202421

Volatility

Volatility Chart

The current Maximized (PSO Pain) volatility is 19.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
19.84%
13.60%
Maximized (PSO Pain)
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

MDIADOGZFTELLASECADLRZLTINSGSEZLWGSTILCRBPJANXASTSSMMT
MDIA1.00-0.030.000.050.03-0.10-0.030.050.06-0.00-0.01-0.020.060.09
DOGZ-0.031.000.07-0.07-0.020.030.08-0.020.120.010.020.100.030.04
FTEL0.000.071.00-0.01-0.020.110.030.110.030.040.100.010.130.00
LASE0.05-0.07-0.011.000.150.010.110.150.130.140.040.090.070.12
CADL0.03-0.02-0.020.151.000.130.130.100.110.110.140.130.140.18
RZLT-0.100.030.110.010.131.000.120.150.120.160.190.260.100.15
INSG-0.030.080.030.110.130.121.000.180.170.150.180.180.250.18
SEZL0.05-0.020.110.150.100.150.181.000.190.190.170.100.250.15
WGS0.060.120.030.130.110.120.170.191.000.140.130.160.220.22
TIL-0.000.010.040.140.110.160.150.190.141.000.200.220.180.30
CRBP-0.010.020.100.040.140.190.180.170.130.201.000.230.220.24
JANX-0.020.100.010.090.130.260.180.100.160.220.231.000.150.27
ASTS0.060.030.130.070.140.100.250.250.220.180.220.151.000.22
SMMT0.090.040.000.120.180.150.180.150.220.300.240.270.221.00
The correlation results are calculated based on daily price changes starting from Aug 18, 2023
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab